HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bi-clonal, multifocal primary cutaneous marginal zone B-cell lymphoma: report of a case and review of the literature.

Abstract
Bi-clonality is a rare phenomenon seen in approximately 5% of chronic B-cell lymphoproliferative disorders. Both true bi-clonality and somatic hypermutation resulting in intraclonal evolution have been described. We present the case of a 37-year-old female who developed extranodal marginal zone B-cell lymphoma with immunohistochemical studies showing monotypic immunostaining of plasma cells for immunoglobulin lambda light chain on her right arm in 2008. Three years later, she developed a second focus of extranodal marginal zone B-cell lymphoma on her left arm, but immunohistochemical studies demonstrated monotypic immunostaining of plasma cells for immunoglobulin kappa light chain confirmed after repeat analysis. Evaluation for systemic lymphoma with laboratory and imaging studies was negative. Together, the findings were consistent with bi-clonal, multifocal extranodal primary cutaneous marginal zone B-cell lymphoma. We present this case to highlight a rare phenomenon within primary cutaneous marginal zone lymphomas.
AuthorsKimberly M Nicholson, Keyur P Patel, Madeleine Duvic, Victor G Prieto, Michael T Tetzlaff
JournalJournal of cutaneous pathology (J Cutan Pathol) Vol. 39 Issue 9 Pg. 866-71 (Sep 2012) ISSN: 1600-0560 [Electronic] United States
PMID22809282 (Publication Type: Case Reports, Journal Article, Review)
CopyrightCopyright © 2012 John Wiley & Sons A/S.
Chemical References
  • Immunoglobulin kappa-Chains
  • Immunoglobulin lambda-Chains
  • Neoplasm Proteins
Topics
  • Adult
  • Female
  • Humans
  • Immunoglobulin kappa-Chains (metabolism)
  • Immunoglobulin lambda-Chains (metabolism)
  • Lymphoma, B-Cell, Marginal Zone (metabolism, pathology)
  • Neoplasm Proteins (metabolism)
  • Plasma Cells (metabolism, pathology)
  • Skin Neoplasms (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: